C07D 239/06
Having one double bond between ring members or between a ring member
Official title: having one double bond between ring members or between a ring member and a non-ring member
C07D239/06 (Having one double bond between ring members or between a ring member) appears on 579 US grants and 353 published applications in this corpus.
Search patents in C07D- Granted patents
- 579
- Published applications
- 353
- Assignees
- 317
- Inventors
- 1,649
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 10 | 0 |
| 1978 | 9 | 0 |
| 1979 | 15 | 0 |
| 1980 | 9 | 0 |
| 1981 | 13 | 0 |
| 1982 | 11 | 0 |
| 1983 | 11 | 0 |
| 1984 | 2 | 0 |
| 1985 | 12 | 0 |
| 1986 | 9 | 0 |
| 1987 | 8 | 0 |
| 1988 | 10 | 0 |
| 1989 | 13 | 0 |
| 1990 | 7 | 0 |
| 1991 | 8 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 9 | 0 |
| 1995 | 14 | 0 |
| 1996 | 6 | 0 |
| 1997 | 18 | 0 |
| 1998 | 23 | 0 |
| 1999 | 15 | 0 |
| 2000 | 18 | 0 |
| 2001 | 17 | 6 |
| 2002 | 29 | 29 |
| 2003 | 17 | 23 |
| 2004 | 17 | 26 |
| 2005 | 13 | 21 |
| 2006 | 9 | 15 |
| 2007 | 9 | 10 |
| 2008 | 14 | 12 |
| 2009 | 6 | 10 |
| 2010 | 8 | 20 |
| 2011 | 6 | 14 |
| 2012 | 14 | 13 |
| 2013 | 19 | 14 |
| 2014 | 19 | 17 |
| 2015 | 13 | 12 |
| 2016 | 11 | 11 |
| 2017 | 9 | 8 |
| 2018 | 10 | 14 |
| 2019 | 10 | 10 |
| 2020 | 9 | 13 |
| 2021 | 4 | 14 |
| 2022 | 11 | 8 |
| 2023 | 6 | 13 |
| 2024 | 7 | 15 |
| 2025 | 5 | 2 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Method for producing uracil compound1 Sep 2026US 12,723,032 B2Nippon Soda Co., Ltd.
- Amidines and amidine analogs for the treatment of bacterial infections and potentiation antibiotics7 Apr 2026US 12,595,251 B2Georgia State University Research Foundation, Inc.
- Compound and composition as PDGF receptor kinase inhibitor30 Dec 2025US 12,509,424 B2Nippon Shinyaku Co., Ltd.
- Cross-linked nucleoside and nucleotide using same18 Nov 2025US 12,473,299 B2Japan AS Represented By Director General of National Institute of Health Sciences
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Ionizable lipidoid compositions and therapeutic uses thereof9 Apr 2026US 2026/0098014 A1Flagship Pioneering Innovations Vii, LLC
- Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid26 Mar 2026US 2026/0085051 A1Adama Agan Ltd.
- Claudin inhibitors and methods of use thereof15 May 2025US 2025/0154110 A1The Board of Trustees of the University of Illinois
- Low temperature synthesis of carbonyl-containing molecules by depolymerization of bisphenol a-based polycarbonates6 Mar 2025US 2025/0074851 A1Basque Center for Macromolecular Design and Engineering, Polymat Fundazioa
Most cited
By later US patents
- Heterocyclic compounds114US 4,742,060 ANihon Tokushu Noyaku Seizo K. K. · 1988
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Muscarinic agonists82US 5,403,845 AThe University of Toledo · 1995
- Muscarinic agonists78US 5,175,166 AThe University of Toledo · 1992